Literature DB >> 14288908

CHOLESTEROL EMBOLISM: A MULTIPLE-SYSTEM DISEASE MASQUERADING AS POLYARTERITIS NODOSA.

A M RICHARDS, R S ELIOT, V I KANJUH, R D BLOEMENDAAL, J E EDWARDS.   

Abstract

Keywords:  ABDOMEN, ACUTE; BLOOD CHOLESTEROL; BLOOD PROTEIN ELECTROPHORESIS; DIAGNOSIS, DIFFERENTIAL; ELECTROCARDIOGRAPHY; EMBOLISM, FAT; GERIATRICS; HYPERTENSION, RENAL; PATHOLOGY; PERIARTERITIS NODOSA

Mesh：

Substances：

Year:  1965        PMID： 14288908     DOI： 10.1016/0002-9149(65)90359-0

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  10 in total

1.  How common is cholesterol embolism?

Authors:  S S Cross
Journal:  J Clin Pathol       Date:  1991-10       Impact factor: 3.411

2.  Atheromatous microemboli.

Authors:  G D Perdue; R B Smith
Journal:  Ann Surg       Date:  1969-06       Impact factor: 12.969

3.  Widespread atheromatous emboli following abdominal aortography.

Authors:  T Nawar; M Cadotte; R Lefebvre; J M Rojo-Ortega; J Genest
Journal:  Can Med Assoc J       Date:  1969-06-07       Impact factor: 8.262

4.  Necrotising glomerulonephritis associated with cholesterol microemboli.

Authors:  M Goldman; Y Thoua; M Dhaene; C Toussaint
Journal:  Br Med J (Clin Res Ed)       Date:  1985-01-19

5.  Atheromatous embolization to the stomach: an unusual cause of gastrointestinal bleeding.

Authors:  R Bourdages; R S Prentice; I T Beck; L R Dacosta; G B Paloschi
Journal:  Am J Dig Dis       Date:  1976-10

6.  Cholesterol crystal embolisation to the alimentary tract.

Authors:  W Moolenaar; C B Lamers
Journal:  Gut       Date:  1996-02       Impact factor: 23.059

7.  Cholesterol embolism as a complication of left heart catheterisation. Report of seven cases.

Authors:  H Drost; B Buis; D Haan; J A Hillers
Journal:  Br Heart J       Date:  1984-09

8.  Microembolic renal disease in rats induced with sephadex.

Authors:  K Solez; G W Richter
Journal:  Am J Pathol       Date:  1972-01       Impact factor: 4.307

Review 9.  Cholesterol embolisation after thrombolytic therapy.

Authors:  J C Blankenship
Journal:  Drug Saf       Date:  1996-02       Impact factor: 5.606

10.  Atheromatous embolic disease.

Authors:  H Schipper; M Gordon; B Berris
Journal:  Can Med Assoc J       Date:  1975-10-04       Impact factor: 8.262
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.